MAPT and Alzheimer disease: At the molecular level, AD pathology is characterized by amyloid beta (Aβ) that forms deposits (senile plaques) and hyperphosphorylated forms of the cytoskeletal protein Tau that aggregate into neurofibrillary tangles (NFT) [69–71].